Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 10345 - 10352 of 12011 results
The ONC’s Health IT Vision Plan: A Building Under Construction
June 13, 2014| Blog| Viewpoint
Proposed Counterfeit Parts Rule Would Expand Coverage to Commercial Products Sold to Any Federal Agency
June 13, 2014| Alert| Viewpoint
SEC Commissioner Aguilar Speaks on Cybersecurity Issues for the Boardroom
June 13, 2014| Blog| Viewpoint
Calling All Boards of Directors: Four Recommendations from the SEC
June 13, 2014| Blog| Viewpoint
Equity Begets Flexibility: Valuing a Secured Creditor’s Claim in Bankruptcy and Allocating Post-Petition Interest
June 13, 2014| Advisory| Viewpoint
No Quorum at Senate Nominations Hearing for CPSC's Adler; Three CPSC Nominees Now Waiting for Committee Action
June 12, 2014| Blog| Viewpoint
U.S. Supreme Court Allows Pom Wonderful to Pursue Lanham Act Claims against Coca-Cola
June 12, 2014| Blog| Viewpoint
UK High Court confirms jurisdiction to grant cross-border declaration of non-infringement
June 11, 2014| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|